ARVN — Arvinas Inc

Arvinas Inc (ARVN) is a biotechnology company listed on NASDAQ. It is led by Randy Teel Ph.D., based in 5 Science Park, New Haven, CT, United States, 06511, with about 246 employees. Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. It is also developing clinical development programs , including ARV-102, a leucine-rich repeat kinase 2 (LRRK2) protein for the treatment of neurodegenerative diseases, such as Parkinson's disease and progressive supranuclear palsy; ARV-806, a Kirsten rat sarcoma, G12D protein for the treatment of cancers with the G12D mutation, comprising pancreatic, colorectal, and non-small cell lung cancer; ARV-393, a B-cell lymphoma 6 protein for the treatment of relapsed/refractory non-Hodgkin lymphoma (NHL); ARV-027, a polyglutamine-expanded androgen receptor in skeletal muscle; and vepdegestrant, an estrogen receptor for the treatment of locally advanced or metastatic ER+/HER2- breast cancer. In addition, the company develops Bavdegalutamide (ARV-110) and Luxdegalutamide (ARV-766), investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer. It has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.

Latest reported ARVN revenue for 2025-09-30 was $41.9M. Net income was -$35.1M. Revenue was up 87.1% from 2025-06-30 to 2025-09-30. ARVN currently screens at market cap $478.7M.

Use this ARVN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ARVN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ARVN SEC filings page. Lician reads the product cache first so this HTML stays unique to Arvinas Inc even when a live quote feed is slow.